Invivo inhibition of glutaminyl cyclase in APP/PS1 transgenic Alzheimer's disease mouse model assessed as reduction in amyloid beta (N3pE to 40) level...

Basic Information

ID: ALA4009743

Type: Functional

Description: Invivo inhibition of glutaminyl cyclase in APP/PS1 transgenic Alzheimer's disease mouse model assessed as reduction in amyloid beta (N3pE to 40) levels in brain administered via deep cortical/hippocampus brain infusion via miniosmotic pumps for 3 weeks

Format: BAO_0000019

Organism: Mus musculus

Target:  Mus musculus(ALA375)

Document:  ALA4007443

Invivo inhibition of glutaminyl cyclase in APP/PS1 transgenic Alzheimer's disease mouse model assessed as reduction in amyloid beta (N3pE to 40) levels in brain administered via deep cortical/hippocampus brain infusion via miniosmotic pumps for 3 weeks: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
468.633.963.96